Welcure Drugs & Pharmaceuticals share news and announcements

BSE: 524661Pharmaceuticals & BiotechnologySmall Cap

₹0.18₹0.02 (10.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹0.20.

52-week range of traded prices to 23 Oct 2026

₹0.17Low, 23 Oct 2026₹0.72High, 23 Oct 2025

Market cap: ₹22 Cr3,646th largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, BSE: 76,25,873

Welcure Drugs & Pharmaceuticals share news and announcements

550 announcements, routine notices left out, newest first. Page 2 of 11.

Aug 2025
- 12 Aug · Legal
  Clarification regarding Intimation of Board Meeting dated 11th August 2025 (opens in a new tab)
- 11 Aug · Board meeting
  Meeting on 22 Aug 2025: bonus issue and stock split
- 11 Aug · Business
  Media Release related to Stock Split and Bonus Issue (opens in a new tab)
- 11 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 22/08/2025 ,inter alia, to consider and approve Stock Split .... (opens in a new tab)
- 5 Aug · Management
  Revised Intimation (Including Resignation Letter) Resignation of Non Executive Independent Director under Regulation 30 of the SEBI(LODR) Regulation, 2015 (opens in a new tab)
- 5 Aug · Management
  Revised Intimation (including the Resignation Letter) of Resignation of Non Executive Non Independent Director in terms of SEBI(LODR) Regulation, 2015 (opens in a new tab)
- 5 Aug
  Intimation Regarding Reconstitution of Committees of the Board of Directors. (opens in a new tab)
- 5 Aug · Management
  Intimation of Resignation Of Non Executive Independent Director under Regulation 30 of the SEBI(LODR) Regulation, 2015 (opens in a new tab)
- 5 Aug · Management
  Intimation/ Disclosure under Regulation 30 of SEBI(LODR) Regulation, 2015 (opens in a new tab)
- 5 Aug · Management
  Intimation / Disclosure under regulation 30 of SEBI (LODR) Regulation 2015. (opens in a new tab)
- 5 Aug · Management
  Intimation/ Disclosure of events under Regulation 30 of Securities and Exchange Board of India( LODR) Regulation, 2015 (opens in a new tab)
- 5 Aug · Management
  Intimation/Disclosure of events under Regulation 30 of the Securities and Exchange Board of India (LODR) Regulation, 2015 (opens in a new tab)
- 5 Aug · Business
  Media Release- Pursuant to Regulation 30 of the Securities and Exchange Board of India (LODR) Reg, 2015. (opens in a new tab)
- 5 Aug · Results
  Standalone Unaudited Financial Results for the 1st Quarter ended 30th June 2025 (opens in a new tab)
- 5 Aug · Results
  Outcome of Board Meeting (opens in a new tab)
Jul 2025
- 31 Jul · Board meeting
  Meeting on 5 Aug 2025: quarterly results
- 31 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 05/08/2025 ,inter alia, to consider and approve 1. To consider .... (opens in a new tab)
- 8 Jul
  Completion of export-sourcing orders aggregating Rs. 299.91 Crores (opens in a new tab)
Jun 2025
- 30 Jun · Welcure Wins New ? 856 Million Export-Sourcing Orders From Giant Exim & Ravina International - Reg-30 Disclosure
  New export sourcing Orders of Rs. 856 Million from Giant Exim & Ravina International (opens in a new tab)
- 18 Jun · Intimation Under Regulation 30 - Rs. 517 Crore Global Sourcing Mandate
  Intimation under Regulation 30 - Rs. 517 Crores Global Sourcing Mandate (opens in a new tab)
- 17 Jun · Meeting
  Voting Result and Scrutinizer's Report of the Postal Ballot (opens in a new tab)
May 2025
- 29 May · Business
  Non Applicability of Filing Statement of Deviation/Variation in Utilization of Funds for Quarter and Year Ended 31st March, 2025 (opens in a new tab)
- 29 May · Management
  Appointment of Secretarial Auditor (opens in a new tab)
- 29 May · Results
  Audited Standalone Financial Results and Audited Standalone Financial Statements along with Auditor's Report of the Company for the quarter and year ended March 31, 2025 (opens in a new tab)
- 29 May · Board meeting
  Outcome of Board Meeting (opens in a new tab)
- 20 May · Board meeting
  Meeting on 29 May 2025: audited results
- 20 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1. To consider .... (opens in a new tab)
- 15 May · Meeting
  Intimation of Notice of Postal Ballot for E-Voting (opens in a new tab)
- 14 May · Management
  Appointment of Managing Director (opens in a new tab)
- 14 May · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
  Amendments to Memorandum of Association (opens in a new tab)
- 14 May · Board meeting
  Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited (opens in a new tab)
- 9 May · Board meeting
  Meeting on 14 May 2025: increase in authorised capital
- 9 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve To consider .... (opens in a new tab)
- 6 May · Management
  Intimation of Appointment of CFO Pursuant to Regulation 30 of SEBI(LODR) Regulation 2015. (opens in a new tab)
- 6 May · Management
  Intimation of Appointment of Company Secretary & Compliance officer pursuant to Regulation 30 of sebi(LODR) Regulation 2015. (opens in a new tab)
- 6 May · Management
  Intimation under Regulation 30 of SEBI(LODR) Regulations 2025. (opens in a new tab)
- 6 May · Board meeting
  Outcome of the Meeting of Board of Directors of Welcure Drugs & Pharmaceuticals Ltd.held on today i.e Tuesday 06th May 2025 (opens in a new tab)
- 6 May · Management
  Intimation of Resignation of Chief Financial officer under regulation 30 of SEBI(LODR) Regulation 2015 (opens in a new tab)
- 6 May · Management
  Intimation of Resignation of Managing Director under regulation 30 of SEBI(LODR) Regulation 2015 (opens in a new tab)
Feb 2025
- 25 Feb · Meeting
  Result of Postal Ballot and Disclosure under Regulation 30, Schedule III, Part A(13)of SEBI (LODR)Regulation 2015. (opens in a new tab)
- 21 Feb · Management
  Intimation of Resignation of Company Secretary and compliance officer under regulation 30 of the SEBI(LODR)Regulation 2015. (opens in a new tab)
- 14 Feb · Results
  INTEGRATED FILING FOR THE QUARTER AND NINE MONTH ENDED DECEMBER 31 2024. (opens in a new tab)
- 14 Feb · Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday 14 February, 2025.
  OUTCOME OF THE MEETING OF THE BOARD OF DIRECTORS OF WELCURE DRUGS AND PHARMACEUTICALS LIMITED HELD ON TODAY 14 FEBRUARY 2025. (opens in a new tab)
- 14 Feb · Results
  Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on today i.e. Friday 14 February, 2025. (opens in a new tab)
- 10 Feb · Board meeting
  Meeting on 14 Feb 2025: quarterly results
- 10 Feb · Business
  Statement of Deviation Variation under regulation 32 of SEBI(LODR) Regulation 2015. (opens in a new tab)
- 10 Feb · Board meeting
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve Intimation .... (opens in a new tab)
Jan 2025

Welcure Drugs & Pharmaceuticals share news and announcements

Aug 2025

Jul 2025

Jun 2025

May 2025

Feb 2025

Jan 2025